Press Releases

Sign up for the latest news

You can unsubscribe at any time using the link at the bottom of any newsletter or contacting info@predictimmune.com

Stay up to date with the latest press releases from PredictImmune and discover how its prognostic tools could help improve the lives of patients with autoimmune diseases through better treatment.

PredictImmune appoints Steven S. Martin as non-executive director

PredictImmune appoints Steven S. Martin as non-executive directorManaging Partner of Paxton Advisors, LLC and ex-CEO of Blue Cross and Blue Shield of Nebraska, appointed with immediate effect Cambridge, UK, 05 November: PredictImmune, developers of pioneering...

PredictImmune announces new strategic partnership

PredictImmune announces new strategic partnership to commercialise its PredictSURE IBDTM prognostic test for inflammatory bowel disease across North AmericaExclusive deal with KSL Biomedical signals PredictImmune’s major move into North America Cambridge, UK, 22...

PredictImmune appoints Tim Rea of BGF as non-executive director

PredictImmune appoints Tim Rea of BGF as non-executive director Experienced entrepreneur and investor appointed with immediate effect Cambridge, UK, 20 August: PredictImmune, developers of pioneering prognostic tools for guiding treatment options and improving patient...

PredictImmune announces closure of £10 Million series B funding round

PredictImmune closes Series B funding round, raising £10M to further accelerate global commercial expansion and support expanding product pipeline New and existing investors demonstrate strong confidence in the developer of unique and pioneering prognostic tools to...